B7-33

B7-33 (5mg) is of scientific interest as a short peptide fragment. Peptides are small chains of amino acids, which are organic molecules that form the building blocks of proteins.

Researchers investigate B7-33 (5mg) to study molecular interactions and peptide behavior in controlled laboratory conditions. The content is strictly research-focused with neutral positioning, and no clinical or therapeutic claims are made.

B7-33 (5mg) is investigated in research settings for structural, biochemical, and signaling studies. The phrase “investigated in research settings” indicates scientific observation without implying any outcomes, benefits, or applications.

Research may include analysis of molecular interactions, peptide stability, or biochemical behavior. Laboratory experiments maintain neutral, non-clinical objectives.

B7-33 (5mg) is intended for laboratory handling only. Standard laboratory safety procedures should be followed during all research activities.

Store B7-33 (5mg) in a controlled environment with appropriate temperature and humidity conditions. Proper storage supports structural stability and reproducibility across batches.

This peptide is not a prescription product and is not suitable for human or veterinary use.

Quality control testing for B7-33 (5mg) includes purity verification through liquid chromatography-mass spectrometry (LC-MS) and other analytical methods. LC-MS separates molecular components and confirms peptide structure and purity.

Batch consistency ensures reproducible experimental results. Analytical documentation accompanies each unit, supporting laboratory compliance and research-grade standards.

Units are labeled with batch numbers, pack size, and verified purity to streamline laboratory workflows and peptide research supply management.

• CAS: 1818415-56-3
• Chemical Formula: C₁₃₁H₂₂₉N₄₁O₃₆S
• Molecular Weight: 2986.54 g/mol
• Peptide Sequence: Val-Ile-Lys-Leu-Ser-Gly-Arg-Glu-Leu-Val-Arg-Ala-Gln-Ile-Ala-Ile-Ser-Gly-Met-Ser-Thr-Trp-Ser-Lys-Arg-Ser-Leu-NH₂
• Shelf life: 24 months from the manufacturing date.

B7-33 (5mg) consists of a biologically characterized peptide fragment. Peptides are composed of amino acids, the organic molecules that form chains to create peptide structures.

Analytical techniques such as mass spectrometry or chromatography are used to confirm molecular structure. These tests verify molecular weight, integrity, and purity, supporting research-grade accuracy.

No additional excipients are included, ensuring consistent peptide purity for laboratory experiments.

Research-Grade Purity

B7-33 (5mg) is produced to research-grade purity standards. Purity refers to the proportion of the intended peptide in each unit. Purity verification ensures consistent quality and reliable results across experiments.

Structurally Defined Peptide Fragment

Structural definition allows reproducible laboratory findings. B7-33 (5mg) is monitored for molecular consistency, which supports accurate peptide research studies.

Designed for Laboratory Workflows

The peptide is supplied in standardized units. Pack size, labeling, and documentation facilitate integration into research workflows. Laboratories can manage peptide research supply efficiently.